can you help with this question – 2 years ago
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →can you help with this question
– 2 years ago
In-depth study guidance and analytical solution covering pROVIDEO.
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Full assignment prompt and step-by-step guidance are included in the downloadable solution file.
– 2 years ago **files (1)** – ## Post1response2.docx **## Post1response2.docx** 200 word response 1 response/intext citation Due 2/2/2025 Sinclair Explain the relevancy to Administrative Law—ie. why does this case relate to our study of Administrative Law—- why is it important for us to know thi…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →– 2 years ago
**files (1)**
– ## Post1response2.docx
**## Post1response2.docx**
200 word response 1 response/intext citation
Due 2/2/2025
Sinclair
Explain the relevancy to Administrative Law—ie. why does this case relate to our study of Administrative Law—- why is it important for us to know this particular case precedent in this field of study?
**1. The name of the case is Abbott Laboratories v. Gardner. The case was brought to Federal Supreme Court and was decided on May 22, 1967.**
**2. In 1962 Congress amended the Federal Food, Drug and Cosmetic Act to require prescription drug manufacturers to print the established name” of a drug “prominently and half as big as the proprietary name or designation of the drug (Mathews, 2024). This is so that doctors and consumers are aware of a cheaper alternative to a drug which is often sold by the established name rather than the proprietary name (brand/trade name) (Mathews, 2024). A similar rule was also made applicable to advertisements for prescription drugs.**
**3. Thirty-seven drug manufacturers sued the FDA Commissioner and Department of Health Secretary before the regulation was enforced stating that this exceeded the Commissioner’s Authority (Mathews, 2024). Initially the District Court ruled in favor of the drug manufacturers then the United States Third Court of Appeals reversed the decision (Quimbee, 2017). Because of this, the case was brought to the United States Supreme Court for decision (Quimbee, 2017).**
**4. The Supreme Court details that under the Administrative Procedure Act, the Court can review administrative decisions (Quimbee, 2017). In so doing, the Supreme Court reversed the Third Courts ruling (Quimbee, 2017).**
**5. The Court’s Rational: Type in the court’s reasons for the holdings. The Supreme Court’s rationals were that unless Congress intended to restrict the authority of the agency, the FDA, then judicial review cannot be withheld (Quimbee, 2017). In this case, Congress did not restrict the FDA. Also, based on the doctrine of Ripeness: which prevents courts from prematurely deciding on abstract issues, agency decisions will not be reviewed unless there is a actual case or controversy “ripe” for review (Quimbee, 2017).**
**The issue was fit for judicial resolution as the commissioner’s authority is a purely legal question and the regulation was a final agency decision. Also, if the judicial review was refused, it would cause hardship to the plaintiffs through potential sanctions if they did not follow the regulation and costs to adhere such as changing labels, advertisements and promotional materials (Quimbee, 2017).**
**## Post1response2.docx**
200 word response 1 response/intext citation
Due 2/2/2025
Sinclair
Explain the relevancy to Administrative Law—ie. why does this case relate to our study of Administrative Law—- why is it important for us to know this particular case precedent in this field of study?
**1. The name of the case is Abbott Laboratories v. Gardner. The case was brought to Federal Supreme Court and was decided on May 22, 1967.**
**2. In 1962 Congress amended the Federal Food, Drug and Cosmetic Act to require prescription drug manufacturers to print the established name” of a drug “prominently and half as big as the proprietary name or designation of the drug (Mathews, 2024). This is so that doctors and consumers are aware of a cheaper alternative to a drug which is often sold by the established name rather than the proprietary name (brand/trade name) (Mathews, 2024). A similar rule was also made applicable to advertisements for prescription drugs.**
**3. Thirty-seven drug manufacturers sued the FDA Commissioner and Department of Health Secretary before the regulation was enforced stating that this exceeded the Commissioner’s Authority (Mathews, 2024). Initially the District Court ruled in favor of the drug manufacturers then the United States Third Court of Appeals reversed the decision (Quimbee, 2017). Because of this, the case was brought to the United States Supreme Court for decision (Quimbee, 2017).**
**4. The Supreme Court details that under the Administrative Procedure Act, the Court can review administrative decisions (Quimbee, 2017). In so doing, the Supreme Court reversed the Third Courts ruling (Quimbee, 2017).**
**5. The Court’s Rational: Type in the court’s reasons for the holdings. The Supreme Court’s rationals were that unless Congress intended to restrict the authority of the agency, the FDA, then judicial review cannot be withheld (Quimbee, 2017). In this case, Congress did not restrict the FDA. Also, based on the doctrine of Ripeness: which prevents courts from prematurely deciding on abstract issues, agency decisions will not be reviewed unless there is a actual case or controversy “ripe” for review (Quimbee, 2017).**
**The issue was fit for judicial resolution as the commissioner’s authority is a purely legal question and the regulation was a final agency decision. Also, if the judicial review was refused, it would cause hardship to the plaintiffs through potential sanctions if they did not follow the regulation and costs to adhere such as changing labels, advertisements and promotional materials (Quimbee, 2017).**
[>Management homework help](https://www.sweetstudy.com/fields/business-finance-management) – 2 years ago **files (2)** – ## Assignment_1_Template_12342.docx – _Assignment_1_details_1244.pdf **## Assignment_1_Template_12342.docx** Playing Field, Competition, and Our Organization **TO:** I _…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →[>Management homework help](https://www.sweetstudy.com/fields/business-finance-management)
– 2 years ago
**files (2)**
– ## Assignment_1_Template_12342.docx
– _Assignment_1_details_1244.pdf
**## Assignment_1_Template_12342.docx**
Playing Field, Competition, and Our Organization
**TO:** I
_nsert name of CEO of selected Company_
**FROM:** _Your name_
**DATE:** _Today’s date_
**RE:** Playing Field, Competition & Our Organization
**(Student to update all sections color-coded in RED and change color to BLACK)**
****1. Introduction and Playing Field Description****
**_Provide an opening paragraph that explains the intended purpose of this Executive Briefing and the topics you intend to cover._**
**| | |**
**| — | — |**
**| a. Company Name and Organization within the company | _Example “Motel Six”_ |**
**| | _Example “Motel Division. (Note: If your company is diverse like Apple, it is advised to analyze a specific segment/business unit/product because competitors in the iPhone segment (Samsung/Google) are very different than competitors in their Music division (Spotify, Pandora)_ |**
**| b. Industry | _Example “Hospitality Industry”_ |**
**| c. Market Size | _Provide a market size estimate for the Industry_<br>_or the Playing Field (Note: This should be the global market and not the size of your current company. The size of your current company goes into the fourth table)_ |**
**| d. Playing Field | _Example: “Two-star motels in the US and Canada serving road travelers.” (Note: this is the specific description of the segment of the industry in which you will compete. These often have geographic boundaries and descriptors of the key product attributes. See Week 2 of the DQ forum.)_ |**
**| e. Rationale for Selection | _Brief explanation of why you selected this segment. (Note: We usually determine target segments based on factors like revenue potential, growth rates, financial attractiveness, conformance with our key capabilities and competencies, our ability to meet this segment’s customer needs, etc.)_ |**
****2. Competitive Analysis****
****Competitor 1:****
****_Company Name_****
**| | |**
**| — | — |**
**| a. Size | _Provide information on the relative size of this competitor in the Playing Field. if specific data is not available, a qualitative description is acceptable like "Company X is believed to be the market leader" or "Company Y is relatively small and focused only in the U.S. and doesn't have a presence in Canada." Try and use the same metric and year for each of the three entities contrasted in this report._ |**
**| b. Most Significant Strength and Weakness | _Describe the competitor’s biggest strength._ |**
**| | _Describe the competitor’s biggest weakness._ |**
**| c. Competitive Impact of Strength and Weakness. | _Briefly explain how this strength and weakness impacts the competitor’s ability to compete effectively._ |**
**| d. Recent Performance | _Describe the competitor’s recent performance. Explain whether the company is generally winning or losing in this Playing Field based on this recent performance. (Note: You would be well-served to support your conclusions with data)_ |**
**| e. Major Developments | _Has the competitor introduced any game-changing new products, technologies, capabilities, etc. (focus on revolutionary and not evolutionary). Have they developed (or lost) a key competitive advantage?_ |**
****Competitor 2:****
****_Company Name_****
**| | |**
**| — | — |**
**| a. Size | _Provide information on the relative size of this competitor in the Playing Field. if specific data is not available, a qualitative description is acceptable like "Company X is believed to be the market leader" or "Company Y is relatively small and focused only in the U.S. and doesn't have a presence in Canada." Try and use the same metric and year for each of the three entities contrasted in this report._ |**
**| b. Most Significant Strength and Weakness | _Describe the competitor’s biggest strength._ |**
**| | _Describe the competitor’s biggest weakness._ |**
**| c. Competitive Impact of Strength and Weakness. | _Briefly explain how this strength and weakness impacts the competitor’s ability to compete effectively._ |**
**| d. Recent Performance | _Describe the competitor’s recent performance. Explain whether the company is generally winning or losing in this Playing Field based on this recent performance. (Note: You would be well-served to support your conclusions with data)_ |**
**| e. Major Developments | _Has the competitor introduced any game-changing new products, technologies, capabilities, etc. (focus on revolutionary and not evolutionary). Have they developed (or lost) a key competitive advantage?_ |**
****3. Organizational Assessment****
**| | |**
**| — | — |**
**| a. Size | _Provide information on our relative size in the Playing Field – qualitative perspective is acceptable if data is not available_ |**
**| b. Most Significant Strength and Weakness | _Highlight our biggest strength._ |**
**| | _Highlight our biggest weakness._ |**
**| c. Competitive Impact of Strength and Weakness. | _Briefly explain how these strengths and weaknesses impact our ability to compete effectively._ |**
**| d. Recent Performance | _Describe our company’s recent performance Explain whether we are generally winning or losing in this Playing Field. (Note: You would be well-served to support your conclusions with data._ |**
**| e. Major Developments | _Have we introduced any game-changing new products, technologies, capabilities, etc. (focus on revolutionary and not evolutionary)? Have we developed (or lost) a key competitive advantage?_ |**
****4. Key Conclusions****
**_Provide a succinct conclusion that captures your critical insights about the target segment and the relative competitive balance of the three companies you analyzed. Define where you think your company is poised in terms of its competitive position against the two competitors you identified._**
****5. References****
**_Include in-text citations for all data, assertions, and facts, and a corresponding reference list. Appendices are allowable if additional supplemental information is needed for the brief._**
**_Assignment_1_details_1244.pdf**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/-assignment-1-details-1244-pdf)
**_Assignment_1_details_1244.pdf**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/-assignment-1-details-1244-pdf)
**## Assignment_1_Template_12342.docx**
Playing Field, Competition, and Our Organization
**TO:** I
_nsert name of CEO of selected Company_
**FROM:** _Your name_
**DATE:** _Today’s date_
**RE:** Playing Field, Competition & Our Organization
**(Student to update all sections color-coded in RED and change color to BLACK)**
****1. Introduction and Playing Field Description****
**_Provide an opening paragraph that explains the intended purpose of this Executive Briefing and the topics you intend to cover._**
**| | |**
**| — | — |**
**| a. Company Name and Organization within the company | _Example “Motel Six”_ |**
**| | _Example “Motel Division. (Note: If your company is diverse like Apple, it is advised to analyze a specific segment/business unit/product because competitors in the iPhone segment (Samsung/Google) are very different than competitors in their Music division (Spotify, Pandora)_ |**
**| b. Industry | _Example “Hospitality Industry”_ |**
**| c. Market Size | _Provide a market size estimate for the Industry_<br>_or the Playing Field (Note: This should be the global market and not the size of your current company. The size of your current company goes into the fourth table)_ |**
**| d. Playing Field | _Example: “Two-star motels in the US and Canada serving road travelers.” (Note: this is the specific description of the segment of the industry in which you will compete. These often have geographic boundaries and descriptors of the key product attributes. See Week 2 of the DQ forum.)_ |**
**| e. Rationale for Selection | _Brief explanation of why you selected this segment. (Note: We usually determine target segments based on factors like revenue potential, growth rates, financial attractiveness, conformance with our key capabilities and competencies, our ability to meet this segment’s customer needs, etc.)_ |**
****2. Competitive Analysis****
****Competitor 1:****
****_Company Name_****
**| | |**
**| — | — |**
**| a. Size | _Provide information on the relative size of this competitor in the Playing Field. if specific data is not available, a qualitative description is acceptable like "Company X is believed to be the market leader" or "Company Y is relatively small and focused only in the U.S. and doesn't have a presence in Canada." Try and use the same metric and year for each of the three entities contrasted in this report._ |**
**| b. Most Significant Strength and Weakness | _Describe the competitor’s biggest strength._ |**
**| | _Describe the competitor’s biggest weakness._ |**
**| c. Competitive Impact of Strength and Weakness. | _Briefly explain how this strength and weakness impacts the competitor’s ability to compete effectively._ |**
**| d. Recent Performance | _Describe the competitor’s recent performance. Explain whether the company is generally winning or losing in this Playing Field based on this recent performance. (Note: You would be well-served to support your conclusions with data)_ |**
**| e. Major Developments | _Has the competitor introduced any game-changing new products, technologies, capabilities, etc. (focus on revolutionary and not evolutionary). Have they developed (or lost) a key competitive advantage?_ |**
****Competitor 2:****
****_Company Name_****
**| | |**
**| — | — |**
**| a. Size | _Provide information on the relative size of this competitor in the Playing Field. if specific data is not available, a qualitative description is acceptable like "Company X is believed to be the market leader" or "Company Y is relatively small and focused only in the U.S. and doesn't have a presence in Canada." Try and use the same metric and year for each of the three entities contrasted in this report._ |**
**| b. Most Significant Strength and Weakness | _Describe the competitor’s biggest strength._ |**
**| | _Describe the competitor’s biggest weakness._ |**
**| c. Competitive Impact of Strength and Weakness. | _Briefly explain how this strength and weakness impacts the competitor’s ability to compete effectively._ |**
**| d. Recent Performance | _Describe the competitor’s recent performance. Explain whether the company is generally winning or losing in this Playing Field based on this recent performance. (Note: You would be well-served to support your conclusions with data)_ |**
**| e. Major Developments | _Has the competitor introduced any game-changing new products, technologies, capabilities, etc. (focus on revolutionary and not evolutionary). Have they developed (or lost) a key competitive advantage?_ |**
****3. Organizational Assessment****
**| | |**
**| — | — |**
**| a. Size | _Provide information on our relative size in the Playing Field – qualitative perspective is acceptable if data is not available_ |**
**| b. Most Significant Strength and Weakness | _Highlight our biggest strength._ |**
**| | _Highlight our biggest weakness._ |**
**| c. Competitive Impact of Strength and Weakness. | _Briefly explain how these strengths and weaknesses impact our ability to compete effectively._ |**
**| d. Recent Performance | _Describe our company’s recent performance Explain whether we are generally winning or losing in this Playing Field. (Note: You would be well-served to support your conclusions with data._ |**
**| e. Major Developments | _Have we introduced any game-changing new products, technologies, capabilities, etc. (focus on revolutionary and not evolutionary)? Have we developed (or lost) a key competitive advantage?_ |**
****4. Key Conclusions****
**_Provide a succinct conclusion that captures your critical insights about the target segment and the relative competitive balance of the three companies you analyzed. Define where you think your company is poised in terms of its competitive position against the two competitors you identified._**
****5. References****
**_Include in-text citations for all data, assertions, and facts, and a corresponding reference list. Appendices are allowable if additional supplemental information is needed for the brief._**
**_Assignment_1_details_1244.pdf**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/-assignment-1-details-1244-pdf)
**## Assignment_1_Template_12342.docx**
Playing Field, Competition, and Our Organization
**TO:** I
_nsert name of CEO of selected Company_
**FROM:** _Your name_
**DATE:** _Today’s date_
**RE:** Playing Field, Competition & Our Organization
**(Student to update all sections color-coded in RED and change color to BLACK)**
****1. Introduction and Playing Field Description****
**_Provide an opening paragraph that explains the intended purpose of this Executive Briefing and the topics you intend to cover._**
**| | |**
**| — | — |**
**| a. Company Name and Organization within the company | _Example “Motel Six”_ |**
**| | _Example “Motel Division. (Note: If your company is diverse like Apple, it is advised to analyze a specific segment/business unit/product because competitors in the iPhone segment (Samsung/Google) are very different than competitors in their Music division (Spotify, Pandora)_ |**
**| b. Industry | _Example “Hospitality Industry”_ |**
**| c. Market Size | _Provide a market size estimate for the Industry_<br>_or the Playing Field (Note: This should be the global market and not the size of your current company. The size of your current company goes into the fourth table)_ |**
**| d. Playing Field | _Example: “Two-star motels in the US and Canada serving road travelers.” (Note: this is the specific description of the segment of the industry in which you will compete. These often have geographic boundaries and descriptors of the key product attributes. See Week 2 of the DQ forum.)_ |**
**| e. Rationale for Selection | _Brief explanation of why you selected this segment. (Note: We usually determine target segments based on factors like revenue potential, growth rates, financial attractiveness, conformance with our key capabilities and competencies, our ability to meet this segment’s customer needs, etc.)_ |**
****2. Competitive Analysis****
****Competitor 1:****
****_Company Name_****
**| | |**
**| — | — |**
**| a. Size | _Provide information on the relative size of this competitor in the Playing Field. if specific data is not available, a qualitative description is acceptable like "Company X is believed to be the market leader" or "Company Y is relatively small and focused only in the U.S. and doesn't have a presence in Canada." Try and use the same metric and year for each of the three entities contrasted in this report._ |**
**| b. Most Significant Strength and Weakness | _Describe the competitor’s biggest strength._ |**
**| | _Describe the competitor’s biggest weakness._ |**
**| c. Competitive Impact of Strength and Weakness. | _Briefly explain how this strength and weakness impacts the competitor’s ability to compete effectively._ |**
**| d. Recent Performance | _Describe the competitor’s recent performance. Explain whether the company is generally winning or losing in this Playing Field based on this recent performance. (Note: You would be well-served to support your conclusions with data)_ |**
**| e. Major Developments | _Has the competitor introduced any game-changing new products, technologies, capabilities, etc. (focus on revolutionary and not evolutionary). Have they developed (or lost) a key competitive advantage?_ |**
****Competitor 2:****
****_Company Name_****
**| | |**
**| — | — |**
**| a. Size | _Provide information on the relative size of this competitor in the Playing Field. if specific data is not available, a qualitative description is acceptable like "Company X is believed to be the market leader" or "Company Y is relatively small and focused only in the U.S. and doesn't have a presence in Canada." Try and use the same metric and year for each of the three entities contrasted in this report._ |**
**| b. Most Significant Strength and Weakness | _Describe the competitor’s biggest strength._ |**
**| | _Describe the competitor’s biggest weakness._ |**
**| c. Competitive Impact of Strength and Weakness. | _Briefly explain how this strength and weakness impacts the competitor’s ability to compete effectively._ |**
**| d. Recent Performance | _Describe the competitor’s recent performance. Explain whether the company is generally winning or losing in this Playing Field based on this recent performance. (Note: You would be well-served to support your conclusions with data)_ |**
**| e. Major Developments | _Has the competitor introduced any game-changing new products, technologies, capabilities, etc. (focus on revolutionary and not evolutionary). Have they developed (or lost) a key competitive advantage?_ |**
****3. Organizational Assessment****
**| | |**
**| — | — |**
**| a. Size | _Provide information on our relative size in the Playing Field – qualitative perspective is acceptable if data is not available_ |**
**| b. Most Significant Strength and Weakness | _Highlight our biggest strength._ |**
**| | _Highlight our biggest weakness._ |**
**| c. Competitive Impact of Strength and Weakness. | _Briefly explain how these strengths and weaknesses impact our ability to compete effectively._ |**
**| d. Recent Performance | _Describe our company’s recent performance Explain whether we are generally winning or losing in this Playing Field. (Note: You would be well-served to support your conclusions with data._ |**
**| e. Major Developments | _Have we introduced any game-changing new products, technologies, capabilities, etc. (focus on revolutionary and not evolutionary)? Have we developed (or lost) a key competitive advantage?_ |**
****4. Key Conclusions****
**_Provide a succinct conclusion that captures your critical insights about the target segment and the relative competitive balance of the three companies you analyzed. Define where you think your company is poised in terms of its competitive position against the two competitors you identified._**
****5. References****
**_Include in-text citations for all data, assertions, and facts, and a corresponding reference list. Appendices are allowable if additional supplemental information is needed for the brief._**
**_Assignment_1_details_1244.pdf**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/-assignment-1-details-1244-pdf)
– 2 years ago **files (1)** – ## ProfessionalIdentityoftheNurseLeaderD3.docx **## ProfessionalIdentityoftheNurseLeaderD3.docx** NUR4590CBE Section 01CBE Professional Identity of the Nurse Leader (11 Weeks) – CBE Online Course – 2025 Winter Quarter Deliverable 3 – Quality Improvement Process Top of F…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →– 2 years ago
**files (1)**
– ## ProfessionalIdentityoftheNurseLeaderD3.docx
**## ProfessionalIdentityoftheNurseLeaderD3.docx**
NUR4590CBE Section 01CBE Professional Identity of the Nurse Leader (11 Weeks) – CBE Online Course – 2025 Winter Quarter
Deliverable 3 – Quality Improvement Process
Top of Form
Bottom of Form
Assignment Content
1.
Top of Form
Question <bdi></bdi>
**Competency**
Apply quality improvement processes utilizing data from outcome measures in the clinical microsystem.
**Student Success Criteria**
View the grading rubric for this deliverable by selecting the “This item is graded with a rubric” link, which is located in the
_Details & Information_ pane.
**Scenario**
You are applying for the role of quality assurance manager at a large health care system. One of the job application requirements is to provide an example of the quality improvement process, from beginning to end, to demonstrate your understanding of how this process requires action at the clinical microsystem level. As a former bedside nurse, you have a wealth of experience to bring to this example and want to be sure to include how continuous quality improvement processes must be applied at this level of care.
**Instructions**
Consider one of the following to identify an example of how quality improvement must be applied to the clinical microsystem:
· HCAHPS Scores
· Medication Error Incident Reports
· A Sentinel Event (death or serious injury not related to the natural course of the client’s illness)
· A breach in protocol or standard of nursing practice
As you develop your example for your job application, include the following elements in a Word document:
· Mechanisms to identify a potential problem regarding quality of service delivery.
· Discuss techniques of data collection that may be required to illustrate the scope of the quality improvement process.
· Identify the structure, process, or outcomes standards to place this quality improvement initiative in a context for action.
· Identify the standards that will be used to gauge the effectiveness of the quality improvement effort.
· Describe steps the organization (system) could or should take to avoid this quality issue in the future.
· Provides stated ideas with professional language and attribution for credible sources with correct APA citation, spelling, and grammar.
**Resources**
·
[https://www.ahrq.gov/cahps/quality-improvement/improvement-guide/4-approach-qi-process/index.html](https://www.ahrq.gov/cahps/quality-improvement/improvement-guide/4-approach-qi-process/index.html)
Bottom of Form
Rubric
·
·
**A – 4 – Mastery**
Thoroughly described mechanisms for a potential problem regarding quality of service delivery.
**0**
**B – 3 – Proficiency**
Clearly described mechanisms for a potential problem regarding quality of service delivery.
**0**
**C – 2 – Competence**
Briefly described mechanisms for a potential problem regarding quality of service delivery.
**0**
**F – 1 – No Pass**
Did not include mechanisms to identify a potential problem.
**0**
**I – 0 – Not Submitted**
Not Submitted
**0**
·
**Criterion 2**
0% of total grade
**A – 4 – Mastery**
Thoroughly discussed techniques of data collection required to illustrate the quality improvement process.
**0**
**B – 3 – Proficiency**
Clearly discussed techniques of data collection required to illustrate the quality improvement process.
**0**
**C – 2 – Competence**
Briefly discussed techniques of data collection required to illustrate the quality improvement process.
**0**
**F – 1 – No Pass**
Did not discuss techniques of data collection.
**0**
**I – 0 – Not Submitted**
Not Submitted
**0**
·
**Criterion 3**
0% of total grade
**A – 4 – Mastery**
Thoroughly identified the structure, process, or outcomes standards to place this quality improvement initiative in a context for action.
**0**
**B – 3 – Proficiency**
Clearly identified the structure, process, or outcomes standards to place this quality improvement initiative in a context for action.
**0**
**C – 2 – Competence**
Briefly identified the structure, process, or outcomes standards to place this quality improvement initiative in a context for action.
**0**
**F – 1 – No Pass**
Does not identify the structure, process, or outcomes standards to place this quality improvement initiative in a context for action.
**0**
**I – 0 – Not Submitted**
Not Submitted
**0**
·
**Criterion 4**
0% of total grade
**A – 4 – Mastery**
Thoroughly described the standards that may be used to gauge effectiveness in the quality improvement effort.
**0**
**B – 3 – Proficiency**
Completely described the standards that may be used to gauge effectiveness in the quality improvement effort.
**0**
**C – 2 – Competence**
Briefly identified the standards that may be used to gauge effectiveness s or success in the quality improvement effort.
**0**
**F – 1 – No Pass**
Did not identify how standards gauge effectiveness of the quality improvement effort.
**0**
**I – 0 – Not Submitted**
Not Submitted
**0**
·
**Criterion 5**
0% of total grade
**A – 4 – Mastery**
Thoroughly described the steps the organization (system) could or should take to avoid this quality issue in the future.
**0**
**B – 3 – Proficiency**
Clearly described the steps the organization (system) could or should take to avoid this quality issue in the future.
**0**
**C – 2 – Competence**
Briefly described the steps the organization (system) could or should take to avoid this quality issue in the future.
**0**
**F – 1 – No Pass**
Did not address the steps the organization (system) could or should take to avoid this quality issue in the future.
**0**
**I – 0 – Not Submitted**
Not Submitted
**0**
·
**Criterion 6**
0% of total grade
**A – 4 – Mastery**
Provided stated ideas with professional language and attribution for credible sources with correct APA citation, spelling, and grammar.
**0**
**B – 3 – Proficiency**
Provided stated ideas with professional language and attribution for credible sources with minimal APA citation, spelling, and grammar errors.
**0**
**C – 2 – Competence**
Attempted to provide stated ideas with professional language and attribution for credible sources with some APA citation, spelling, and grammar errors.
**0**
**F – 1 – No Pass**
Provided confusing ideas with an attempt at professional language and attribution for credible sources with numerous APA citation, spelling, and grammar errors.
**0**
**I – 0 – Not Submitted**
APA and grammar
**## ProfessionalIdentityoftheNurseLeaderD3.docx**
NUR4590CBE Section 01CBE Professional Identity of the Nurse Leader (11 Weeks) – CBE Online Course – 2025 Winter Quarter
Deliverable 3 – Quality Improvement Process
Top of Form
Bottom of Form
Assignment Content
1.
Top of Form
Question <bdi></bdi>
**Competency**
Apply quality improvement processes utilizing data from outcome measures in the clinical microsystem.
**Student Success Criteria**
View the grading rubric for this deliverable by selecting the “This item is graded with a rubric” link, which is located in the
_Details & Information_ pane.
**Scenario**
You are applying for the role of quality assurance manager at a large health care system. One of the job application requirements is to provide an example of the quality improvement process, from beginning to end, to demonstrate your understanding of how this process requires action at the clinical microsystem level. As a former bedside nurse, you have a wealth of experience to bring to this example and want to be sure to include how continuous quality improvement processes must be applied at this level of care.
**Instructions**
Consider one of the following to identify an example of how quality improvement must be applied to the clinical microsystem:
· HCAHPS Scores
· Medication Error Incident Reports
· A Sentinel Event (death or serious injury not related to the natural course of the client’s illness)
· A breach in protocol or standard of nursing practice
As you develop your example for your job application, include the following elements in a Word document:
· Mechanisms to identify a potential problem regarding quality of service delivery.
· Discuss techniques of data collection that may be required to illustrate the scope of the quality improvement process.
· Identify the structure, process, or outcomes standards to place this quality improvement initiative in a context for action.
· Identify the standards that will be used to gauge the effectiveness of the quality improvement effort.
· Describe steps the organization (system) could or should take to avoid this quality issue in the future.
· Provides stated ideas with professional language and attribution for credible sources with correct APA citation, spelling, and grammar.
**Resources**
·
[https://www.ahrq.gov/cahps/quality-improvement/improvement-guide/4-approach-qi-process/index.html](https://www.ahrq.gov/cahps/quality-improvement/improvement-guide/4-approach-qi-process/index.html)
Bottom of Form
Rubric
·
·
**A – 4 – Mastery**
Thoroughly described mechanisms for a potential problem regarding quality of service delivery.
**0**
**B – 3 – Proficiency**
Clearly described mechanisms for a potential problem regarding quality of service delivery.
**0**
**C – 2 – Competence**
Briefly described mechanisms for a potential problem regarding quality of service delivery.
**0**
**F – 1 – No Pass**
Did not include mechanisms to identify a potential problem.
**0**
**I – 0 – Not Submitted**
Not Submitted
**0**
·
**Criterion 2**
0% of total grade
**A – 4 – Mastery**
Thoroughly discussed techniques of data collection required to illustrate the quality improvement process.
**0**
**B – 3 – Proficiency**
Clearly discussed techniques of data collection required to illustrate the quality improvement process.
**0**
**C – 2 – Competence**
Briefly discussed techniques of data collection required to illustrate the quality improvement process.
**0**
**F – 1 – No Pass**
Did not discuss techniques of data collection.
**0**
**I – 0 – Not Submitted**
Not Submitted
**0**
·
**Criterion 3**
0% of total grade
**A – 4 – Mastery**
Thoroughly identified the structure, process, or outcomes standards to place this quality improvement initiative in a context for action.
**0**
**B – 3 – Proficiency**
Clearly identified the structure, process, or outcomes standards to place this quality improvement initiative in a context for action.
**0**
**C – 2 – Competence**
Briefly identified the structure, process, or outcomes standards to place this quality improvement initiative in a context for action.
**0**
**F – 1 – No Pass**
Does not identify the structure, process, or outcomes standards to place this quality improvement initiative in a context for action.
**0**
**I – 0 – Not Submitted**
Not Submitted
**0**
·
**Criterion 4**
0% of total grade
**A – 4 – Mastery**
Thoroughly described the standards that may be used to gauge effectiveness in the quality improvement effort.
**0**
**B – 3 – Proficiency**
Completely described the standards that may be used to gauge effectiveness in the quality improvement effort.
**0**
**C – 2 – Competence**
Briefly identified the standards that may be used to gauge effectiveness s or success in the quality improvement effort.
**0**
**F – 1 – No Pass**
Did not identify how standards gauge effectiveness of the quality improvement effort.
**0**
**I – 0 – Not Submitted**
Not Submitted
**0**
·
**Criterion 5**
0% of total grade
**A – 4 – Mastery**
Thoroughly described the steps the organization (system) could or should take to avoid this quality issue in the future.
**0**
**B – 3 – Proficiency**
Clearly described the steps the organization (system) could or should take to avoid this quality issue in the future.
**0**
**C – 2 – Competence**
Briefly described the steps the organization (system) could or should take to avoid this quality issue in the future.
**0**
**F – 1 – No Pass**
Did not address the steps the organization (system) could or should take to avoid this quality issue in the future.
**0**
**I – 0 – Not Submitted**
Not Submitted
**0**
·
**Criterion 6**
0% of total grade
**A – 4 – Mastery**
Provided stated ideas with professional language and attribution for credible sources with correct APA citation, spelling, and grammar.
**0**
**B – 3 – Proficiency**
Provided stated ideas with professional language and attribution for credible sources with minimal APA citation, spelling, and grammar errors.
**0**
**C – 2 – Competence**
Attempted to provide stated ideas with professional language and attribution for credible sources with some APA citation, spelling, and grammar errors.
**0**
**F – 1 – No Pass**
Provided confusing ideas with an attempt at professional language and attribution for credible sources with numerous APA citation, spelling, and grammar errors.
**0**
**I – 0 – Not Submitted**
APA and grammar
This is on the peer review article that was completed already…… 200 plus word count Use thorough and appropriate research Use appropriate APA formatting Use effective grammar with minimal errors Flow logically and use expected structural elements – [\ \ AbstractDevelopmentOutline.docx](https:/…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →This is on the peer review article that was completed already……
200 plus word count
Use thorough and appropriate research
Use appropriate APA formatting
Use effective grammar with minimal errors
Flow logically and use expected structural elements
– [\
\
AbstractDevelopmentOutline.docx](https://www.sweetstudy.com/files/abstractdevelopmentoutline-docx "AbstractDevelopmentOutline.docx")
– [\
\
BrowsingPeerReviewedJournals.docx](https://www.sweetstudy.com/files/browsingpeerreviewedjournals-docx "BrowsingPeerReviewedJournals.docx")
– 2 years ago
– 2 years ago **files (1)** – ## Week4TR.docx **## Week4TR.docx** Choose a state and review the scope of practice for the advanced practice nurse. How does it compare to Florida? **Submission Instructions:** · Your initial post should be at least 500 words, formatted and cited in current APA style w…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →– 2 years ago
**files (1)**
– ## Week4TR.docx
**## Week4TR.docx**
Choose a state and review the scope of practice for the advanced practice nurse. How does it compare to Florida?
**Submission Instructions:**
· Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources. Your initial post is worth 8 points.
· Please write in paragraph form, no bullet points
· Please do not use textbooks as reference only peer-reviewed scholarly articles from within 4 years time.
**## Week4TR.docx**
Choose a state and review the scope of practice for the advanced practice nurse. How does it compare to Florida?
**Submission Instructions:**
· Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources. Your initial post is worth 8 points.
· Please write in paragraph form, no bullet points
· Please do not use textbooks as reference only peer-reviewed scholarly articles from within 4 years time.
– 2 years ago **files (1)** – ## Week42.docx **## Week42.docx** **Reproductive Function:** Ms. P.C. is a 19-year-old white female who reports a 2-day history of lower abdominal pain, nausea, emesis and a heavy, malodorous vaginal discharge. She states that she is single, heterosexual, and that she h…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →– 2 years ago
**files (1)**
– ## Week42.docx
**## Week42.docx**
**Reproductive Function:** Ms. P.C. is a 19-year-old white female who reports a 2-day history of lower abdominal pain, nausea, emesis and a heavy, malodorous vaginal discharge. She states that she is single, heterosexual, and that she has been sexually active with only one partner for the past eight months. She has no previous history of genitourinary infections or sexually transmitted diseases. She denies IV drug use. Her LMP ended three days ago. Her last intercourse (vaginal) was eight days ago and she states that they did not use a condom. She admits to unprotected sex “every once in a while.” She noted an abnormal vaginal discharge yesterday and she describes it as “thick, greenish-yellow in color, and very smelly.” She denies both oral and rectal intercourse. She does not know if her partner has had a recent genitourinary tract infection, “because he has been away on business for five days.
Microscopic Examination of Vaginal Discharge
(-) yeast or hyphae
(-) flagellated microbes
(+) white blood cells
(+) gram-negative intracellular diplococci
**Case Study Questions**
1. According to the case presented, including the clinical manifestations and microscopic examination of the vaginal discharge, what is the most probably diagnosis for Ms. P.C.? Support your answer and explain why you get to that diagnosis.
2. Based on the vaginal discharged described and the microscopic examination of the sample could you suggest which would be the microorganism involved?
3. Name the criteria you would use to recommend hospitalization for this patient
**Submission Instructions:**
· Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources. Your initial post is worth 8 points.
· Please write in paragraph form, no bullet points
· Please do not use textbooks as reference only peer-reviewed scholarly articles from within 4 years time.
**## Week42.docx**
**Reproductive Function:** Ms. P.C. is a 19-year-old white female who reports a 2-day history of lower abdominal pain, nausea, emesis and a heavy, malodorous vaginal discharge. She states that she is single, heterosexual, and that she has been sexually active with only one partner for the past eight months. She has no previous history of genitourinary infections or sexually transmitted diseases. She denies IV drug use. Her LMP ended three days ago. Her last intercourse (vaginal) was eight days ago and she states that they did not use a condom. She admits to unprotected sex “every once in a while.” She noted an abnormal vaginal discharge yesterday and she describes it as “thick, greenish-yellow in color, and very smelly.” She denies both oral and rectal intercourse. She does not know if her partner has had a recent genitourinary tract infection, “because he has been away on business for five days.
Microscopic Examination of Vaginal Discharge
(-) yeast or hyphae
(-) flagellated microbes
(+) white blood cells
(+) gram-negative intracellular diplococci
**Case Study Questions**
1. According to the case presented, including the clinical manifestations and microscopic examination of the vaginal discharge, what is the most probably diagnosis for Ms. P.C.? Support your answer and explain why you get to that diagnosis.
2. Based on the vaginal discharged described and the microscopic examination of the sample could you suggest which would be the microorganism involved?
3. Name the criteria you would use to recommend hospitalization for this patient
**Submission Instructions:**
· Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources. Your initial post is worth 8 points.
· Please write in paragraph form, no bullet points
· Please do not use textbooks as reference only peer-reviewed scholarly articles from within 4 years time.
– 2 years ago **files (1)** – ## Week41.docx **## Week41.docx** **Urinary Function:** Mr. J.R. is a 73-year-old man, who was admitted to the hospital with clinical manifestations of gastroenteritis and possible renal injury. The patient’s chief complaints are fever, nausea with vomiting and diarrhea…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →– 2 years ago
**files (1)**
– ## Week41.docx
**## Week41.docx**
**Urinary Function:** Mr. J.R. is a 73-year-old man, who was admitted to the hospital with clinical manifestations of gastroenteritis and possible renal injury. The patient’s chief complaints are fever, nausea with vomiting and diarrhea for 48 hours, weakness, dizziness, and a bothersome metallic taste in the mouth. The patient is pale and sweaty. He had been well until two days ago, when he began to experience severe nausea several hours after eating two burritos for supper. The burritos had been ordered from a local fast-food restaurant. The nausea persisted and he vomited twice with some relief. As the evening progressed, he continued to feel “very bad” and took some Pepto-Bismol to help settle his stomach. Soon thereafter, he began to feel achy and warm. His temperature at the time was 100. 5°F. He has continued to experience nausea, vomiting, and a fever. He has not been able to tolerate any solid foods or liquids. Since yesterday, he has had 5–6 watery bowel movements. He has not noticed any blood in the stools. His wife brought him to the ER because he was becoming weak and dizzy when he tried to stand up. His wife denies any recent travel, use of antibiotics, laxatives, or excessive caffeine, or that her husband has an eating disorder.
**Case Study Questions**
1. The attending physician is thinking that Mr. J.R. has developed an Acute Kidney Injury (AKI). Analyzing the case presented name the possible types of Acute Kidney Injury. Link the clinical manifestations described to the different types of Acute Kidney injury.
2. Create a list of risk factors the patient might have and explain why.
3. Unfortunately, the damage on J.R. kidney became irreversible and he is now diagnosed with Chronic kidney disease. Please describe the complications that the patient might have on his Hematologic system (Coagulopathy and Anemia) and the pathophysiologic mechanisms involved.
**Submission Instructions:**
· Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources. Your initial post is worth 8 points.
· Please write in paragraph form, no bullet points
· Please do not use textbooks as reference only peer-reviewed scholarly articles from within 4 years time.
**## Week41.docx**
**Urinary Function:** Mr. J.R. is a 73-year-old man, who was admitted to the hospital with clinical manifestations of gastroenteritis and possible renal injury. The patient’s chief complaints are fever, nausea with vomiting and diarrhea for 48 hours, weakness, dizziness, and a bothersome metallic taste in the mouth. The patient is pale and sweaty. He had been well until two days ago, when he began to experience severe nausea several hours after eating two burritos for supper. The burritos had been ordered from a local fast-food restaurant. The nausea persisted and he vomited twice with some relief. As the evening progressed, he continued to feel “very bad” and took some Pepto-Bismol to help settle his stomach. Soon thereafter, he began to feel achy and warm. His temperature at the time was 100. 5°F. He has continued to experience nausea, vomiting, and a fever. He has not been able to tolerate any solid foods or liquids. Since yesterday, he has had 5–6 watery bowel movements. He has not noticed any blood in the stools. His wife brought him to the ER because he was becoming weak and dizzy when he tried to stand up. His wife denies any recent travel, use of antibiotics, laxatives, or excessive caffeine, or that her husband has an eating disorder.
**Case Study Questions**
1. The attending physician is thinking that Mr. J.R. has developed an Acute Kidney Injury (AKI). Analyzing the case presented name the possible types of Acute Kidney Injury. Link the clinical manifestations described to the different types of Acute Kidney injury.
2. Create a list of risk factors the patient might have and explain why.
3. Unfortunately, the damage on J.R. kidney became irreversible and he is now diagnosed with Chronic kidney disease. Please describe the complications that the patient might have on his Hematologic system (Coagulopathy and Anemia) and the pathophysiologic mechanisms involved.
**Submission Instructions:**
· Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources. Your initial post is worth 8 points.
· Please write in paragraph form, no bullet points
· Please do not use textbooks as reference only peer-reviewed scholarly articles from within 4 years time.
response is needed Hello everyone, **Describe the specific pathophysiological processes in SLE that lead to the manifestations observed in your assigned body system. How does SLE affect your assigned body system?** Systemic Lupus Erythematosus (SLE) is an autoimmune disease that affects the pulmonar…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →response is needed
Hello everyone,
**Describe the specific pathophysiological processes in SLE that lead to the manifestations observed in your assigned body system. How does SLE affect your assigned body system?**
Systemic Lupus Erythematosus (SLE) is an autoimmune disease that affects the pulmonary system mainly through inflammation. Autoantibodies and immune complexes attack lung tissue, causing pleuritis, Interstitial Lung Disease (ILD), and pulmonary hypertension (Shin et al., 2022). Symptoms of pleuritis include acute chest aches and labored breathing. For pulmonary system, scarring and inflammation from ILD induce lung rigidity, which impairs gas exchange.
**Discuss the symptoms and clinical manifestations of SLE on your assigned body system. How do these symptoms impact the client’s function and quality of life? Can changes in your assigned body system affect or be affected by other body systems in clients with SLE?**
Cough, dyspnea, chest pain, and weariness are SLE pulmonary symptoms. These symptoms limit mobility and lower the client's quality of life, making walking or stair climbing difficult (Depascale et al., 2021). Interstitial lung illness can cause fatigue and reduced exercise tolerance, like chronic hypoxia. Pulmonary changes can be linked to cardiovascular stress in right-sided heart failure patients with pulmonary hypertension. If only the renal, cardiovascular, and immune systems are inflamed, pulmonary changes can increase systemic inflammation. This reciprocal body structure activation worsens SLE treatment.
**Discuss the diagnostic tests used to diagnose SLE-related complications in your body system. What challenges are associated with diagnosing SLE if only looking at your assigned body system?**
Imaging and functional testing are needed to diagnose pulmonary involvement in SLE. High-resolution Computed Tomography (CT) scans or chest X-rays are needed to confirm chest opacities, pleural effusion, or lung fibrosis in suspected interstitial lung disease. Pulmonary Function Tests (PFTs) of lung volume and diffusing capacity can also confirm interstitial lung disease (Zamboti et al., 2021). Diagnosing SLE through the pulmonary system is quite challenging since its symptoms are very much related to asthma.
**Explore the current treatments for managing SLE symptoms associated with your assigned body system. What are the goals of these treatments, and how effective are they in mitigating the impact of SLE on the body?**
SLE pulmonary manifestations require inflammation control, lung tissue preservation, and symptom suppression. Corticosteroids like prednisone are anti-inflammatory. Medications like mycophenolate mofetil and azathioprine weaken the immune system. Sildenafil and other vasodilators treat pulmonary hypertension. Continuous oxygen supply is also sometimes required for chronic hypoxic conditions (Agarwal et al., 2021). The main goal of this medicines is to manage the disease and slow its progression but cannot repair the damage. They are effective in a way they protect lung function and minimize SLE's health impacts.
**References**
Agarwal, T., Kazemi, S., Costantini, M., Perfeito, F., Correia, C. R., Gaspar, V., Montazeri, L., De Maria, C., Mano, J. F., Vosough, M., Makvandi, P., & Maiti, T. K. (2021). Oxygen releasing materials: Towards addressing the hypoxia-related issues in tissue engineering. _Materials Science and Engineering: C_, _122_, 111896. [https://doi.org/10.1016/j.msec.2021.111896Links to an external site.](https://doi.org/10.1016/j.msec.2021.111896)
Depascale, R., Del Frate, G., Gasparotto, M., Manfrè, V., Gatto, M., Iaccarino, L., Quartuccio, L., De Vita, S., & Doria, A. (2021). Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren’s syndrome: A literature review. _Therapeutic Advances in Musculoskeletal Disease_, _13_, 1–24. [https://doi.org/10.1177/1759720x211040696Links to an external site.](https://doi.org/10.1177/1759720×211040696)
Shin, J. I., Lee, K. H., Park, S., Yang, J. W., Kim, H. J., Song, K., Lee, S., Na, H., Jang, Y. J., Nam, J. Y., Kim, S., Lee, C., Hong, C., Kim, C., Kim, M., Choi, U., Seo, J., Jin, H., Yi, B., & Jeong, S. J. (2022). Systemic lupus erythematosus and lung involvement: A comprehensive review. _Journal of Clinical Medicine_, _11_(22), 6714. [https://doi.org/10.3390/jcm11226714Links to an external site.](https://doi.org/10.3390/jcm11226714)
Zamboti, C. L., Cristina, A., Garcia, T., Krinski, G. G., Bertin, L. D., Almeida, S., Pimpão, H. A., Fujisawa, D. S., Ribeiro, M. A., Pitta, F., & Camillo, C. A. (2021). Functional performance tests in interstitial lung disease: Impairment and measurement properties. _Respiratory Medicine_, _184_, 106413. [https://doi.org/10.1016/j.rmed.2021.106413](https://doi.org/10.1016/j.rmed.2021.106413)
– 2 years ago